Correlation Between Ubiquitech Software and Sunshine Biopharma
Can any of the company-specific risk be diversified away by investing in both Ubiquitech Software and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ubiquitech Software and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ubiquitech Software and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Ubiquitech Software and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ubiquitech Software with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ubiquitech Software and Sunshine Biopharma.
Diversification Opportunities for Ubiquitech Software and Sunshine Biopharma
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Ubiquitech and Sunshine is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Ubiquitech Software and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Ubiquitech Software is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ubiquitech Software are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Ubiquitech Software i.e., Ubiquitech Software and Sunshine Biopharma go up and down completely randomly.
Pair Corralation between Ubiquitech Software and Sunshine Biopharma
Given the investment horizon of 90 days Ubiquitech Software is expected to generate 13.54 times more return on investment than Sunshine Biopharma. However, Ubiquitech Software is 13.54 times more volatile than Sunshine Biopharma Warrant. It trades about 0.27 of its potential returns per unit of risk. Sunshine Biopharma Warrant is currently generating about 0.31 per unit of risk. If you would invest 0.01 in Ubiquitech Software on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Ubiquitech Software or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ubiquitech Software vs. Sunshine Biopharma Warrant
Performance |
| Timeline |
| Ubiquitech Software |
| Sunshine Biopharma |
Ubiquitech Software and Sunshine Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ubiquitech Software and Sunshine Biopharma
The main advantage of trading using opposite Ubiquitech Software and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ubiquitech Software position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.| Ubiquitech Software vs. Now Corp | Ubiquitech Software vs. Holloman Energy Corp | Ubiquitech Software vs. Greater Cannabis | Ubiquitech Software vs. EVIO Inc |
| Sunshine Biopharma vs. Sunshine Biopharma | Sunshine Biopharma vs. Thayer Ventures Acquisition | Sunshine Biopharma vs. Biofrontera Warrants | Sunshine Biopharma vs. Neurosense Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |